Literature DB >> 14988740

Effect of pre- and posttreatment of losartan in feline model of myocardial ischemic-reperfusion injury.

R Kumari1, S C Manchanda, S K Maulik.   

Abstract

This study investigated the differential effect of losartan, an AT1 receptor blocker, when administered in pre- and postischemic phases, on the biochemical, hemodynamic and oxidative stress associated with regional ischemic-reperfusion injury in cat. Losartan (5 microg/kg/min) or normal saline was administered intravenously in open chest barbiturate anesthetized cats, 15 min before and 10 min after the occlusion of the left anterior descending (LAD) coronary artery. The LAD was occluded for 15 min followed by 60 min reperfusion. In the saline treated group, there was significant depression of hemodynamic functions, i.e., mean arterial pressure (MAP), heart rate (HR), left ventricular end diastolic pressure (LVEDP) and left ventricular (LV) peak (+/-) dP/dt, along with depletion of adenosine triphosphate (ATP) of the affected myocardium. Oxidative stress during reperfusion injury was evidenced by significant increase in plasma thiobarbituric acid reactive substances (TBARS) accompanied by significant reduction in myocardial superoxide dismutase (SOD) activities. In both treatment groups, losartan caused recovery of all the hemodynamic parameters and repletion of ATP along with no significant change in plasma TBARS and myocardial SOD activity. There was no effect on catalase activity. Results from the study suggest that the effects of pre- and posttreatment of losartan are comparable in functional recovery of the heart from ischemic-reperfusion injury. (c) 2004 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988740     DOI: 10.1358/mf.2004.26.1.793471

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  2 in total

1.  Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model.

Authors:  Dimitrios N Nikas; Georgios Chatziathanasiou; Anna Kotsia; Nikos Papamichael; Christoforos Thomas; Michail Papafaklis; Katerina K Naka; Nikos Kazakos; Haralampos J Milionis; Kostas Vakalis; Christos S Katsouras; Vasiliki Mpoumpa; Theodoros Vougiouklakis; Lampros Michalis
Journal:  Curr Ther Res Clin Exp       Date:  2008-10

2.  Rat mRNA expression profiles associated with inhibition of ischemic acute kidney injury by losartan.

Authors:  Yijin Wu; Wenying Peng; Ru Wei; Yanhe Zhou; Miaoxian Fang; Siyi Liu; Yujun Deng; Qi Yin; Xin Ouyang; Linhui Hu; Yating Hou; Chunbo Chen
Journal:  Biosci Rep       Date:  2019-04-09       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.